Is CBT a Buy or a Sell? The Bull and Bear Case (2026)

That depends on which case you find more convincing, and both are on this page. The bull case rests on Tire contract pricing and volume recovery, with revenue (ttm) at ~$3.6 billion (June 2026 quarter ~$982 million, up ~6% year over year). The bear case rests on the biggest risk is that tire pricing keeps resetting lower. Analysts covering it are spread from $78.00 to $100.00, which is itself a signal that this is genuinely contested. If you believe the thesis, the real questions become sizing and overlap rather than timing. Walnut is not an investment adviser and this is not a recommendation.

Nobody can answer that for you, and the honest version of the question is narrower: has anything changed in the reason you bought it? The bear case on this page is the place to check. The biggest risk is that tire pricing keeps resetting lower. If that risk is what you were worried about and it is now playing out, that is a real signal. If the price simply fell while the thesis held, that is a different situation entirely. The most pessimistic published target is $78.00, +5.6% from the $73.86 price, which is one analyst's downside case rather than a floor. Walnut is not an investment adviser.

Tire contract pricing and volume recovery. Reinforcement Materials is still about 60% of sales and most of the profit, so the annual tire contract negotiation is the single biggest swing factor. The most optimistic analyst target on CBT is $100.00, +35.4% from the $73.86 price. That figure is only reachable if this thesis works close to its best case.

The biggest risk is that tire pricing keeps resetting lower. Western tire makers face heavy competition from low-cost Asian imports, and if they keep losing share or push Cabot harder in the calendar 2027 contract round, Reinforcement Materials earnings could fall again even with higher volumes. Feedstock is another exposure: carbon black is made from heavy oil residues, and while contracts include pass-through mechanisms, sharp oil swings can squeeze margins for a quarter or two. Cabot runs energy-intensive plants that emit significant CO2, so tighter European carbon pricing and US EPA consent-decree obligations raise compliance costs. Battery materials face fierce price competition from Chinese nanotube makers and depend on an electric vehicle market that has slowed in the West. Restructuring brings execution risk, and the Botlek closures still need local approval. A CEO transition adds strategic uncertainty, the former CEO sold about 25% of his stake in August, and Cabot's large operations in China, Indonesia and Latin America expose it to currency moves, tariffs and geopolitical disruption. Finally, analyst consensus sits at Hold, with targets clustered near the current price. The most pessimistic published target is $78.00, +5.6% from the current price, which is roughly what the stock is worth if these risks bite rather than the drivers.

Boston-based specialty chemicals company and the world's largest carbon black maker, supplying tire makers, plastics and battery materials.

Decide that in advance, because it is far harder to think clearly once a position is moving against you. The concrete tripwires here: the driver behind the bull case (Tire contract pricing and volume recovery) stalling in the reported numbers rather than in the narrative, the risk above (the biggest risk is that tire pricing keeps resetting lower) turning from a possibility into a reported fact, or the position growing large enough that a bad outcome would matter to your whole portfolio regardless of who is right.

Cabot's core product is carbon black, a fine black powder made by partially burning heavy oil feedstocks. Roughly 70% of the world's carbon black ends up in tires, where it reinforces rubber and improves wear and grip; the rest goes into belts, hoses, seals and other rubber goods. That business sits in the Reinforcement Materials segment, about 60% of sales. The Performance Chemicals segment makes specialty carbon blacks that color and protect plastics, wire and cable and coatings; fumed silica and alumina used in silicones, adhesives and chip polishing slurries; inkjet colorants; and conductive additives for lithium-ion batteries. Cabot sold its activated carbon purification business in 2024, so today it is essentially a two-segment company built around carbon and particle chemistry, with plants on every major continent.

Through the first three quarters of fiscal 2026, adjusted EPS came in at ~$1.53, ~$1.61 and ~$1.67, each down roughly 12% to 13% from a year earlier but rising sequentially. The June quarter brought ~$982 million in sales, up ~6%, and slightly beat consensus. Reinforcement Materials EBIT fell ~24% to ~$97 million because calendar 2026 tire contracts settled at lower margins per ton, while Performance Chemicals EBIT rose ~19% to ~$68 million on battery materials and specialty grades. GAAP net income was only ~$6 million that quarter after ~$1.55 per share of restructuring and benefit plan charges. Management guided full-year adjusted EPS to ~$6.15 to $6.45, versus $7.25 in fiscal 2025, with final results due in early November 2026.

Cabot negotiates most tire grade carbon black supply on annual calendar-year contracts with large tire makers. Over 2025 Western tire producers lost share to low-cost imported tires from Asia, which left them with lower utilization and more pressure on suppliers. Cabot's own volumes in the Americas and Europe softened, and in the calendar 2026 negotiations it accepted lower gross profit per ton to hold volume. The result was segment EBIT down ~22% to ~29% year over year in each of the first three fiscal quarters, even as volumes recovered later in the year, helped by a new Indonesian plant and a Mexican producer acquired in early 2026. Trade duties on imported tires and the calendar 2027 contract round, negotiated this autumn, are the main things that could change the trend.